|
Baker, Kathryn T; Salk, Jesse J; Brentnall, Teresa A et al. (2018) Precancer in ulcerative colitis: the role of the field effect and its clinical implications. Carcinogenesis 39:11-20
|
|
Klein, Jason C; Keith, Aidan; Agarwal, Vikram et al. (2018) Functional characterization of enhancer evolution in the primate lineage. Genome Biol 19:99
|
|
Halpern, Anna B; Othus, Megan; Huebner, Emily M et al. (2018) Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms. Leukemia :
|
|
Hart, Matthew R; Anderson, Donovan J; Porter, Christopher C et al. (2018) Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations. PLoS Genet 14:e1007642
|
|
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334
|
|
Samuelson Bannow, B T; Konkle, B A (2018) Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review. Thromb Res 163:138-145
|
|
Wang, Tzu-Fei; Li, Ang; Garcia, David (2018) Managing thrombosis in cancer patients. Res Pract Thromb Haemost 2:429-438
|
|
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
|
|
Correnti, Colin E; Laszlo, George S; de van der Schueren, Willem J et al. (2018) Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation. Leukemia 32:1239-1243
|
|
Li, A; Khalighi, P R; Wu, Q et al. (2018) External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. J Thromb Haemost 16:164-169
|
Showing the most recent 10 out of 105 publications
